Search Results 691-700 of 14350 for Incidence

  1. Diroximel fumarate (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Back pain; black, tarry stools; bloating of the stomach; blurred vision; chest tightness; confusion; constipation; dark urine; diarrhea ...

  2. Selexipag (intravenous route) - Side effects & uses - Mayo Clinic

    Incidence not known. Blue lips and fingernails; blurred vision; chest pain; confusion; coughing that sometimes produces a pink frothy sputum; difficult, fast ...

  3. COVID-19 diagnostic testing - Mayo Clinic

    These tests look for genetic material from the COVID-19 virus. Polymerase chain reaction tests, shortened to PCR tests, are molecular tests. The lab technique ...

  4. Caffeine and sodium benzoate (injection route) - Mayo Clinic

    Incidence not known. Anxiety; continuing ringing or buzzing or other unexplained noise in the ears; headache; hearing loss; hyperventilation; increased ...

  5. Ferric pyrophosphate citrate (route not applicable) - Side effects & uses - Mayo Clinic

    Incidence not known. Cough; difficulty with breathing or swallowing; hives, itching, or skin rash; nausea; puffiness or swelling of the eyelids or around the ...

  6. Do Imaging Agents Cause Acute Kidney Injury? Mayo Study Questions the Connection

    Our goal for these studies was to provide better evidence regarding the true incidence of renal injury following intravenous contrast administration and better ...

  7. Gemcitabine (intravenous route) - Side effects & uses - Mayo Clinic

    Incidence not known. Blue lips and fingernails; cloudy urine; coughing that sometimes produces a pink frothy sputum; dark urine; decrease or increase in the ...

  8. Sodium nitrite and sodium thiosulfate (intravenous route) - Mayo Clinic

    Incidence not known. Bluish color of the fingernails, lips, skin, palms, or nail beds; blurred vision; change in consciousness; confusion; dark urine; difficult ...

  9. Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation - Mayo Clinic

    The purpose of this study is to determine the incidence of rPSC in LT recipients treated with fenofibrate, compared with an untreated control cohort.

  10. Breast Cancer - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    BOADICEA score. The Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) score is a combined score used to estimate ...